169 related articles for article (PubMed ID: 24823643)
1. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
3. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
4. Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Molecules; 2015 Jul; 20(7):12076-92. PubMed ID: 26147581
[TBL] [Abstract][Full Text] [Related]
5. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
Shi NQ; Gao W; Xiang B; Qi XR
Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Crisp JL; Savariar EN; Glasgow HL; Ellies LG; Whitney MA; Tsien RY
Mol Cancer Ther; 2014 Jun; 13(6):1514-25. PubMed ID: 24737028
[TBL] [Abstract][Full Text] [Related]
7. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
Waschkau B; Faust A; Schäfers M; Bremer C
Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.
Chen S; Cui J; Jiang T; Olson ES; Cai QY; Yang M; Wu W; Guthrie JM; Robertson JD; Lipton SA; Ma L; Tsien RY; Gu Z
J Cereb Blood Flow Metab; 2017 Jan; 37(1):188-200. PubMed ID: 26681768
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
Kondo N; Temma T; Shimizu Y; Ono M; Saji H
Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
[TBL] [Abstract][Full Text] [Related]
10. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Felsen CN; Savariar EN; Whitney M; Tsien RY
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733
[TBL] [Abstract][Full Text] [Related]
11. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
[TBL] [Abstract][Full Text] [Related]
12. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.
Bremer C; Bredow S; Mahmood U; Weissleder R; Tung CH
Radiology; 2001 Nov; 221(2):523-9. PubMed ID: 11687699
[TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745
[TBL] [Abstract][Full Text] [Related]
14. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
15. The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.
Li S; Chen J; Xu H; Long J; Xie X; Zhang Y
PLoS One; 2014; 9(7):e100670. PubMed ID: 25000246
[TBL] [Abstract][Full Text] [Related]
16. [The design and enzymatic hydrolysis of activatable cell-penetrating peptide].
Wang PC; Qi XR
Yao Xue Xue Bao; 2010 Aug; 45(8):1048-51. PubMed ID: 21351594
[TBL] [Abstract][Full Text] [Related]
17. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
18. In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate.
Chuang CH; Chuang KH; Wang HE; Roffler SR; Shiea JT; Tzou SC; Cheng TC; Kao CH; Wu SY; Tseng WL; Cheng CM; Hou MF; Wang JM; Cheng TL
Clin Cancer Res; 2012 Jan; 18(1):238-47. PubMed ID: 22019516
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide.
Du Y; Lin X; Feng Q; Pan X; Song S; Yang J
Anticancer Drugs; 2022 Jan; 33(1):e562-e572. PubMed ID: 34338241
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
